Catalyst Wire Dossier Catalyst Wire Dossier

BALFAXAR

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BALFAXAR, covering 2025-06-04 to 2025-06-04. Get the full timeline:

Most recent: Clinical Trial Update: Post Marketing Observational Study on Safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure

See pricing